Mean Corpuscular Volume (MCV) to monitor azathioprine and 6-mercaptopurine in Inflammatory Bowel Disease (IBD) patients

被引：0
|
作者：
Sarraj, R. [1 ,2 ]
Pittet, V. [1 ,2 ]
Michetti, P. [1 ,2 ]
Felley, C. [1 ,2 ]
Mottet, C. [1 ,2 ]
Buclin, T. [1 ,2 ]
机构：
[1] Univ Lausanne & Hosp Ctr CHUV, Lausanne, Switzerland
[2] SWISS IBD Cohort Study SIBDCS, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2011年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G14
引用
收藏
页码：14S / 14S
页数：1
相关论文
共 50 条
  • [1] Relationship of thiopurine methyltransferase (TPMT) activity to mean corpuscular volume (MCV) in inflammatory bowel disease (IBD) patients maintained on azathioprine
    Joy, D
    MacPherson, R
    Campbell, S
    Kingstone, K
    Ghosh, S
    GUT, 2002, 50 : A79 - A79
  • [2] Erythrocyte mean corpuscular volume (MCV) as a surrogate marker for 6-thioguanine nucleotide (6TGN) concentration monitoring in patients with Inflammatory Bowel Disease (IBD) treated with azathioprine (AZA) or 6-mercaptopurine (6MP)
    Thomas, CW
    Lowry, PW
    Franklin, CL
    Weaver, AL
    Myhre, G
    Mays, DC
    Tremaine, WJ
    Lipsky, JJ
    Sandborn, WJ
    GASTROENTEROLOGY, 2002, 122 (04) : A222 - A222
  • [3] Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease
    Marion, JF
    INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 116 - 117
  • [4] Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
    Thomas, CW
    Lowry, PW
    Franklin, CL
    Weaver, AL
    Myhre, GM
    Mays, DC
    Tremaine, WJ
    Lipsky, JJ
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2003, 9 (04) : 237 - 245
  • [5] AZATHIOPRINE/6-MERCAPTOPURINE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) - A SINGLE CENTRE EXPERIENCE
    Costantino, G.
    Sergi, M. D.
    Lo Presti, M. A.
    Della Torre, A.
    Corrente, E.
    Ocera, L.
    Di Benedetto, A.
    Romano, C.
    Fries, W.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S134 - S135
  • [6] AZATHIOPRINE, 6-MERCAPTOPURINE, AND INFLAMMATORY BOWEL-DISEASE
    BEAUGERIE, L
    GENDRE, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (03): : 230 - 240
  • [7] Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine
    Su, CY
    Lichtenstein, GR
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 209 - +
  • [8] Tolerability of 6-mercaptopurine in azathioprine intolerant patients with inflammatory bowel disease
    Lees, Charlie
    Maan, Ajeet
    Hansoti, Bhakti
    Penman, Ian D.
    Shand, Alan G.
    Palmer, Kelvin R.
    Arnott, Ian D.
    Satsangi, Jack
    GASTROENTEROLOGY, 2007, 132 (04) : A185 - A185
  • [9] Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
    Kirschner, BS
    GASTROENTEROLOGY, 1998, 115 (04) : 813 - 821
  • [10] Tolerability of 6-mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease
    Lees, C. W.
    Maan, A. K.
    Hansoti, B.
    Penman, I. D.
    Shand, A. G.
    Palmer, K. R.
    Arnott, I. D. R.
    Satsangi, J.
    GUT, 2007, 56 : A24 - A24
12345